Amgen
AMGN
2,322 hedge funds and large institutions have $92.3B invested in Amgen in 2022 Q3 according to their latest regulatory filings, with 113 funds opening new positions, 951 increasing their positions, 868 reducing their positions, and 117 closing their positions.
10% more repeat investments, than reductions
Existing positions increased: 951 | Existing positions reduced: 868
0.78% less ownership
Funds ownership: 77.45% → 76.67% (-0.78%)
3% less first-time investments, than exits
New positions opened: 113 | Existing positions closed: 117
1% less funds holding
Funds holding: 2,352 → 2,322 (-30)
8% less capital invested
Capital invested by funds: $100B → $92.3B (-$8.1B)
9% less funds holding in top 10
Funds holding in top 10: 93 → 85 (-8)
12% less call options, than puts
Call options by funds: $1.37B | Put options by funds: $1.56B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
+$474M |
| 2 |
Goldman Sachs
New York
|
+$464M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$318M |
| 4 |
Amundi
Paris,
France
|
+$190M |
| 5 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
+$133M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$568M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$361M |
| 3 |
Nordea Investment Management
Stockholm,
Sweden
|
-$216M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$212M |
| 5 |
Millennium Management
New York
|
-$197M |
AMGN Hedge Fund Activity: Q3 2022 in Review
2,322 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q3 2022, worth a combined $92.3B — down 8.1% from $100B a quarter earlier.
Sellers outnumbered buyers: 117 funds closed out of AMGN and 113 opened new positions — a net loss of 4 holders — while 868 trimmed existing stakes and 951 added.
The largest buyer was Norges Bank, adding an estimated $474M. The largest seller was Morgan Stanley, cutting an estimated $568M.
- 2,322 institutional investors held Amgen (AMGN) as of Q3 2022, down from 2,352 in Q2 2022.
- Funds reported $92.3B of Amgen stock for Q3 2022, down 8.1% quarter-over-quarter.
- 113 funds opened new Amgen positions in Q3 2022 and 117 closed out, a net change of -4 holders.
- The largest Amgen buyer in Q3 2022 was Norges Bank, an estimated $474M added.
- The largest Amgen seller in Q3 2022 was Morgan Stanley, an estimated $568M sold.
Based on aggregated 13F filings for Q3 2022.